Professor Muy-Teck Teh is a pioneering molecular biologist and global leader in oral oncology. With 28+ years of research and teaching experience, he is Professor of Molecular Oral Oncology at Queen Mary University of London and a Fellow of the UK Higher Education Academy. He earned his BSc (Hons) in Biomedical Science (1996) and PhD in Physiology (2000) from King’s College London, followed by postdoctoral fellowships from the Wellcome Trust and Cancer Research UK. His work focuses on translating molecular discoveries into clinical applications for head and neck cancers. Professor Teh has authored over 70 peer-reviewed papers (5,700+ citations, h-index 38) in top journals like Nature Genetics and Molecular Cancer. His research bridges transcriptome pattern recognition and biomarker discovery. His seminal work on FOXM1 earned the Molecule of the Year award (2010). He invented qMIDS (2020), the first FOXM1-based molecular diagnostic test for early head and neck cancer detection, validated the 2nd generation qMIDS-V2 in a 535-patient multicohort study across the UK, China, and India. He is now developing qMIDS-V3, a non-invasive oral brush biopsy test, and an EBV-independent test (qMIDS-NPC) for nasopharyngeal cancer risk stratification.